Third dose of Pfizer-BioNTech vaccine increases neutralizing antibody levels against SARS-CoV-2

Retrieved on: 2021-09-19 19:07:30

Tags for this article:

Coronaviridae

Viruses

Sarbecovirus

Zoonoses

Bat virome

Severe acute respiratory syndrome

Severe acute respiratory syndrome coronavirus 1

Severe acute respiratory syndrome–related coronavirus

Karen Mossman

Click the tags to see associated articles and topics

Third dose of Pfizer-BioNTech vaccine increases neutralizing antibody levels against SARS-CoV-2. View article details on hiswai:

Excerpt

Pfizer, BioNTech and University of Texas Medical Branch scientists tracked the immune response of participants in clinical trials for the vaccine. They found ...

Article found on: www.news-medical.net

View Original Article